Follow
Omu Anzala
Omu Anzala
Professor of Virology and immunology .KAVI-Institute of Clinical Research.University of Nairobi
Verified email at uonbi.ac.ke
Title
Cited by
Cited by
Year
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
DH Barouch, SV Kik, GJ Weverling, R Dilan, SL King, LF Maxfield, S Clark, ...
Vaccine 29 (32), 5203-5209, 2011
3422011
Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort
E Landais, X Huang, C Havenar-Daughton, B Murrell, MA Price, ...
PLoS pathogens 12 (1), e1005369, 2016
2822016
Standardization of cytokine flow cytometry assays
HT Maecker, A Rinfret, P D'Souza, J Darden, E Roig, C Landry, P Hayes, ...
BMC immunology 6, 1-18, 2005
2792005
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa
E Karita, N Ketter, MA Price, K Kayitenkore, P Kaleebu, A Nanvubya, ...
PloS one 4 (2), e4401, 2009
2062009
Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection
OA Anzala, NJD Nagelkerke, JJ Bwayo, D Holton, S Moses, EN Ngugi, ...
Journal of Infectious Diseases 171 (3), 686-689, 1995
1881995
Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers
G Mutua, E Sanders, P Mugo, O Anzala, JE Haberer, D Bangsberg, ...
PloS one 7 (4), e33103, 2012
1802012
Recombination following superinfection by HIV-1
G Fang, B Weiser, C Kuiken, SM Philpott, S Rowland-Jones, F Plummer, ...
Aids 18 (2), 153-159, 2004
1662004
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa
MA Price, CL Wallis, S Lakhi, E Karita, A Kamali, O Anzala, EJ Sanders, ...
AIDS research and human retroviruses 27 (1), 5-12, 2011
1532011
Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth
MA Price, W Rida, M Mwangome, G Mutua, K Middelkoop, S Roux, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (2), 185-193, 2012
1482012
Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa
E Karita, M Price, E Hunter, E Chomba, S Allen, L Fei, A Kamali, ...
Aids 21 (4), 403-408, 2007
1452007
Early antibody lineage diversification and independent limb maturation lead to broad HIV-1 neutralization targeting the Env high-mannose patch
DT MacLeod, NM Choi, B Briney, F Garces, LS Ver, E Landais, B Murrell, ...
Immunity 44 (5), 1215-1226, 2016
1352016
IL‐7Rα expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation
SA Koesters, JB Alimonti, C Wachihi, L Matu, O Anzala, J Kimani, ...
European journal of immunology 36 (2), 336-344, 2006
1342006
Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa
PN Amornkul, E Karita, A Kamali, WN Rida, EJ Sanders, S Lakhi, ...
Aids 27 (17), 2775-2786, 2013
1182013
Safety and immunogenicity of a 2-dose heterologous vaccine regimen with Ad26. ZEBOV and MVA-BN-Filo Ebola vaccines: 12-month data from a phase 1 randomized clinical trial in …
G Mutua, O Anzala, K Luhn, C Robinson, V Bockstal, D Anumendem, ...
The Journal of infectious diseases 220 (1), 57-67, 2019
1152019
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa
W Jaoko, E Karita, K Kayitenkore, G Omosa-Manyonyi, S Allen, S Than, ...
PloS one 5 (9), e12873, 2010
1142010
Bombali virus in Mops condylurus bat, Kenya
KM Forbes, PW Webala, AJ Jääskeläinen, S Abdurahman, J Ogola, ...
Emerging Infectious Diseases 25 (5), 955, 2019
1082019
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
W Jaoko, FN Nakwagala, O Anzala, GO Manyonyi, J Birungi, A Nanvubya, ...
Vaccine 26 (22), 2788-2795, 2008
1052008
Identification of preferential CD4+ T-cell targets for HIV infection in the cervix
VR Joag, LR McKinnon, J Liu, ST Kidane, MH Yudin, B Nyanga, ...
Mucosal immunology 9 (1), 1-12, 2016
932016
Assessment of the safety and immunogenicity of 2 novel vaccine platforms for HIV-1 prevention: a randomized trial
LR Baden, E Karita, G Mutua, LG Bekker, G Gray, L Page-Shipp, ...
Annals of internal medicine 164 (5), 313-322, 2016
912016
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates
A Spentzou, P Bergin, D Gill, H Cheeseman, A Ashraf, H Kaltsidis, ...
The Journal of infectious diseases 201 (5), 720-729, 2010
852010
The system can't perform the operation now. Try again later.
Articles 1–20